About ESPERION THERAPEUTICS INC
Innovation Today, for Healthier Lives Tomorrow
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Ann Arbor, Michigan
- Founded
- 2008
- Company type
- Public Company
- Company profile name
- Esperion
Official LinkedIn page for Esperion. Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative cardiometabolic and rare/orphan disease therapies. The Company leverages deep domain expertise in ACLY biology to develop and commercialize transformative medicines for patients worldwide. Esperion currently markets two oral, once-daily, non-statin therapies for patients struggling to maintain their low-density lipoprotein cholesterol (LDL-C) levels and are at risk of cardiovascular disease.
With a broad U.S. commercial infrastructure and global approvals across more than 40 countries, Esperion is well positioned to serve as a partner-of-choice for global innovators seeking U.S. market access through acquisition, in-license, co-promotion and revenue share opportunities. In tandem, the Company is advancing its leadership in ACLY biology to build a diversified pipeline of novel product candidates, including treatments for Primary Sclerosing Cholangitis and renal diseases.
Community guidelines:
Certified Great Place To Work®
Specialties
- Late-state Pharmaceutical Company
- Small Molecule
- LDL-C
- Statin
- Cardiovascular
- and Research & Development
Company locations
3891 Ranchero Dr, Ann Arbor, Michigan 48108, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 24,288
- People linked to this company
- 347
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.